5 小时
News-Medical.Net on MSNTransforming genetic deafness treatment with base editingCongenital hearing loss refers to impaired auditory function that occurs due to genetic causes. GJB2 is the gene responsible ...
Learn more about whether Qualys, Inc. or Workiva Inc. is a better investment based on AAII's A+ Investor grades, which ...
A cybersecurity company that combats AI deepfakes called GetReal Security has closed a $17.5 million in a Series A funding ...
DelveInsight's "LUXTURNA Market Size, Forecast, and Market Insight Report" highlights the details around LUXTURNA, a one-time ...
18 小时
News-Medical.Net on MSNNovel drug nitisinone could help reduce malaria spread by killing mosquitoesNitisinone was shown to last longer than ivermectin in the human bloodstream, and was able to kill not only mosquitoes of all ...
D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment ...
Eluvio Bangkok Release and Application Suite to be showcased at NAB 2025 in Meeting Room W237, Sports Hub Booth W1974A, and ...
Get free Clive Barker's Jericho Steam accounts and keys! Learn how to unlock this horror classic without paying. Follow the ...
Max 2026 introduces OpenPBR as the default material, enhances the Vertex Weld Modifier for splines, and boosts performance across key modifiers.
This research, conducted by Bitdefender Labs, presents the first documented analysis of a ransomware campaign attributed to ...
LUXTURNA has significant market potential due to the high unmet need for effective treatments in rare genetic conditions. With its FDA approval for specific mutations in the RPE65 gene, it offers ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果